NT-proB natriuretic peptide, risk factors and asymptomatic left ventricular dysfunction: Results of the SCReening Evaluation of the Evolution of New Heart Failure Study (SCREEN-HF)-Reference-Cited by-同舟云学术

NT-proB natriuretic peptide, risk factors and asymptomatic left ventricular dysfunction: Results of the SCReening Evaluation of the Evolution of New Heart Failure Study (SCREEN-HF)

Published:2013-10 Issue:2 Volume:169 Page:133-138
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

McGrady Michele,Reid Christopher M.,Shiel Louise,Wolfe Rory,Boffa Umberto,Liew Danny,Campbell Duncan J,Prior David,Stewart Simon,Krum Henry

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference51 articles.

1. Screening: the new frontier in heart failure management;McGrady;Cardiovasc Ther,2009

2. Crunch time for heart failure care in England and Wales;Lancet,2010

3. Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population;McDonagh;Lancet,1997

4. Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: a population based study;Davies;Lancet,2001

5. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic;Redfield;JAMA,2003

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of sleep on chronobiology of micturition among healthy older adults;American Journal of Physiology-Renal Physiology;2023-10-01

2. Heart failure diagnosis in the general community – Who, how and when? A clinical consensus statement of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC);European Journal of Heart Failure;2023-07-17

3. Mis-reporting of energy intake among older Australian adults: Prevalence, characteristics, and associations with quality of life;Nutrition;2021-10

4. Biomarkers in Heart Failure;Heart Failure Clinics;2021-04

5. Biomarkers;Precision Medicine in Cardiovascular Disease Prevention;2021